Dyadic International, Inc. (DYAI)
NASDAQ·Healthcare·Biotechnology
$0.82
+0.00%
Mkt Cap $28.95M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 25, 2026 | $1.34M | $564.35K | -57.99% | -$0.03 | -$0.06 | -100.00% | — | — |
| Q4 2025 Nov 12, 2025 | $1.34M | $1.16M | -13.30% | -$0.04 | -$0.06 | -50.00% | — | — |
| Q3 2025 Aug 13, 2025 | $1.50M | $463.45K | -69.10% | -$0.06 | -$0.06 | +0.00% | — | — |
| Q2 2025 May 14, 2025 | — | $393.57K | — | — | -$0.07 | — | — | — |
| Q1 2025 Mar 26, 2025 | $1.60M | $817.38K | -48.91% | -$0.04 | -$0.05 | -25.00% | — | — |
| Q4 2024 Nov 12, 2024 | $1.60M | $1.96M | +22.34% | -$0.07 | -$0.01 | +85.71% | — | — |
| Q3 2024 Aug 13, 2024 | $1.00M | $385.90K | -61.41% | -$0.07 | -$0.07 | +0.00% | — | — |
| Q2 2024 May 14, 2024 | — | $334.62K | — | — | -$0.07 | — | — | — |
| Q1 2024 Mar 28, 2024 | $800.00K | $686.53K | -14.18% | -$0.07 | -$0.08 | -14.29% | — | — |
| Q4 2023 Nov 8, 2023 | $800.00K | $397.06K | -50.37% | -$0.06 | -$0.06 | +0.00% | — | — |
| Q3 2023 Aug 9, 2023 | $1.30M | $837.16K | -35.60% | -$0.05 | -$0.07 | -40.00% | — | — |
| Q2 2023 May 10, 2023 | — | $978.05K | — | — | -$0.03 | — | — | — |
| Q1 2023 Mar 29, 2023 | $1.45M | $743.73K | -48.71% | -$0.07 | -$0.07 | +0.00% | — | — |
| Q4 2022 Nov 10, 2022 | $1.90M | $879.60K | -53.71% | -$0.10 | -$0.06 | +40.00% | — | — |
| Q3 2022 Aug 10, 2022 | $1.84M | $658.55K | -64.21% | -$0.09 | -$0.12 | -33.33% | — | — |
| Q2 2022 May 12, 2022 | $2.36M | $648.43K | -72.56% | -$0.09 | -$0.09 | +0.00% | — | — |
| Q1 2022 Mar 29, 2022 | $171.50K | $313.29K | +82.68% | -$0.03 | -$0.15 | -500.00% | — | — |
| Q4 2021 Nov 10, 2021 | $873.09K | $692.93K | -20.63% | -$0.10 | -$0.06 | +40.00% | — | — |
| Q3 2021 Aug 12, 2021 | $937.00K | $937.09K | +0.01% | -$0.09 | -$0.14 | -55.56% | — | — |
| Q2 2021 May 13, 2021 | $1.38M | $460.52K | -66.67% | $0.09 | -$0.12 | -233.33% | — | — |